Cite
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas.
MLA
Gluud, Maria, et al. “MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas.” Cancers, vol. 12, no. 5, May 2020, p. 1229. EBSCOhost, https://doi.org/10.3390/cancers12051229.
APA
Gluud, M., Willerslev-Olsen, A., Gjerdrum, L. M. R., Lindahl, L. M., Buus, T. B., Andersen, M. H., Bonefeld, C. M., Krejsgaard, T., Litvinov, I. V., Iversen, L., Becker, J. C., Persson, J. L., Koralov, S. B., Litman, T., Geisler, C., Woetmann, A., & Odum, N. (2020). MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas. Cancers, 12(5), 1229. https://doi.org/10.3390/cancers12051229
Chicago
Gluud, Maria, Andreas Willerslev-Olsen, Lise Mette Rahbek Gjerdrum, Lise M. Lindahl, Terkild B. Buus, Mads Hald Andersen, Charlotte Menne Bonefeld, et al. 2020. “MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas.” Cancers 12 (5): 1229. doi:10.3390/cancers12051229.